AAN 2018 DAILY REPORT

 

Report from the American Academy of Neurology annual meeting, Los Angeles, April 21-27, 2018

Thursday Edition
Wednesday Edition
Tuesday Edition


CONGRESS HIGHLIGHTS – THURSDAY EDITION

Treatment studies in neurology

MS
Dimethyl fumarate
Alemtuzumab
Ocrelizumab
Oral cladribine
Natalizumab
Migraine
Erenumab
Fremanezumab

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page